Analyst picks & changes

Genetics Institute Inc.

(GENIZ)

Business: Biopharmaceuticals

Cowen's Lonergan reiterated a "buy" on the Cambridge, Mass., company, seeing a favorable product

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.